Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zinc gluconate for treating cold symptoms needs more research -- JAMA study.

This article was originally published in The Tan Sheet

Executive Summary

ZINC SUPPLEMENTATION FOR COMMON COLD REQUIRES ADDITIONAL RESEARCH following the negative results of a 247-patient pediatric trial, Michael Macknin, MD, Cleveland Clinic Foundation, et al., report in the June 24 Journal of the American Medical Association. "Additional studies in all age groups with different dosages and formulations of zinc lozenges and with virologic testing are needed to define what role, if any, zinc has in the treatment of common cold symptoms," the researchers say. The study found that zinc lozenges did not provide improved relief of cold symptoms compared to placebo in children and adolescents in grades 1-12.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel